Progesterone modulates pro-inflammatory cytokine expression profile after spinal cord injury: Implications for neuropathic pain
- PMID: 26943964
- DOI: 10.1016/j.jneuroim.2016.01.011
Progesterone modulates pro-inflammatory cytokine expression profile after spinal cord injury: Implications for neuropathic pain
Abstract
Neuropathic pain is a frequent complication of spinal cord injury (SCI), still refractory to conventional treatment. Glial cell activation and cytokine production contribute to the pathology of central neuropathic syndromes. In this study we evaluated the effects of progesterone, a neuroactive steroid, on pain development and the spinal expression of IL-1β, its receptors (IL-1RI and IL-1RII) and antagonist (IL-1ra), IL-6 and TNFα, and NR1 subunit of NMDAR. Our results show that progesterone, by modulating the expression of pro-inflammatory cytokines and neuronal IL-1RI/NR1 colocalization, emerges as a promising agent to prevent chronic pain after SCI.
Keywords: Chronic pain; Glial activation; NMDA receptor; Neuroactive steroids; Pro-inflammatory cytokines; Spinal cord.
Copyright © 2016 Elsevier B.V. All rights reserved.
Similar articles
-
Progesterone prevents allodynia after experimental spinal cord injury.J Pain. 2011 Jan;12(1):71-83. doi: 10.1016/j.jpain.2010.04.013. Epub 2010 Aug 2. J Pain. 2011. PMID: 20675200
-
Neuropathic pain and temporal expression of preprodynorphin, protein kinase C and N-methyl-D-aspartate receptor subunits after spinal cord injury.Neurosci Lett. 2008 Dec 12;447(2-3):115-9. doi: 10.1016/j.neulet.2008.09.062. Epub 2008 Sep 30. Neurosci Lett. 2008. PMID: 18835424
-
Progesterone reduces the expression of spinal cyclooxygenase-2 and inducible nitric oxide synthase and prevents allodynia in a rat model of central neuropathic pain.Eur J Pain. 2014 Mar;18(3):348-59. doi: 10.1002/j.1532-2149.2013.00376.x. Epub 2013 Aug 8. Eur J Pain. 2014. PMID: 23929706
-
Therapeutic potential of progesterone in spinal cord injury-induced neuropathic pain: At the crossroads between neuroinflammation and N-methyl-D-aspartate receptor.J Neuroendocrinol. 2023 Feb;35(2):e13181. doi: 10.1111/jne.13181. Epub 2022 Aug 4. J Neuroendocrinol. 2023. PMID: 35924434 Review.
-
Astrocytes as a target for neuroprotection: Modulation by progesterone and dehydroepiandrosterone.Prog Neurobiol. 2016 Sep;144:27-47. doi: 10.1016/j.pneurobio.2016.03.010. Epub 2016 Apr 2. Prog Neurobiol. 2016. PMID: 27048624 Review.
Cited by
-
Hormonal therapy in traumatic spinal cord injury.Am J Transl Res. 2017 Sep 15;9(9):3881-3895. eCollection 2017. Am J Transl Res. 2017. PMID: 28979667 Free PMC article. Review.
-
Sex dimorphic regulation of osteoprogenitor progesterone in bone stromal cells.J Mol Endocrinol. 2017 Nov;59(4):351-363. doi: 10.1530/JME-17-0076. Epub 2017 Sep 4. J Mol Endocrinol. 2017. PMID: 28871061 Free PMC article.
-
Translocator Protein 18 kDa (TSPO) as a Novel Therapeutic Target for Chronic Pain.Neural Plast. 2022 Aug 29;2022:8057854. doi: 10.1155/2022/8057854. eCollection 2022. Neural Plast. 2022. PMID: 36071748 Free PMC article. Review.
-
Inhibition of aquaporin-4 and its subcellular localization attenuates below-level central neuropathic pain by regulating astrocyte activation in a rat spinal cord injury model.Neurotherapeutics. 2024 Mar;21(2):e00306. doi: 10.1016/j.neurot.2023.e00306. Epub 2023 Dec 19. Neurotherapeutics. 2024. PMID: 38237380 Free PMC article.
-
Progesterone and Allopregnanolone Neuroprotective Effects in the Wobbler Mouse Model of Amyotrophic Lateral Sclerosis.Cell Mol Neurobiol. 2022 Jan;42(1):23-40. doi: 10.1007/s10571-021-01118-y. Epub 2021 Jun 17. Cell Mol Neurobiol. 2022. PMID: 34138412 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical